ALDER BIOPHARMACEUTICALS INC Human Resources Contracts & Agreements
20 Contracts & Agreements
- Bonus & Incentive Agreements (9 contracts)
- Change of Control Agreements (1)
- Compensation Agreements (1)
- Consulting Agreements (4)
- Severance Agreements (4)
- Transition Agreements (1)
- Alder BioPharmaceuticals, Inc. Executive Severance Benefit Plan, effective October 18, 2019 (Filed With SEC on October 22, 2019)
- Form of Stock Option Grant Notice and Option Agreement for the 2014 Equity Incentive Plan (for Initial Grants) (Filed With SEC on August 6, 2019)
- Form of Stock Option Grant Notice and Option Agreement for the 2014 Equity Incentive Plan (for Annual Grants) (Filed With SEC on August 6, 2019)
- Compensation Information for Non-Employee Directors (Filed With SEC on May 2, 2019)
- Transition and Consulting Agreement between Alder BioPharmaceuticals, Inc. and John A. Latham, Ph.D. dated March 28, 2019 (Filed With SEC on May 2, 2019)
- Amendment to Offer Letter between Alder BioPharmaceuticals, Inc. and Carlos E. Campoy dated February 7, 2019. X 10.32+ Amended and Restated Executive Severance Benefit Plan (Filed With SEC on February 25, 2019)
- Transition Agreement between Alder BioPharmaceuticals, Inc. and Elisabeth A. Sandoval, dated November 2, 2018 (Filed With SEC on February 25, 2019)
- Amendment to Separation and Consulting Agreement with Randy Schatzman dated September 12, 2018 (Filed With SEC on November 5, 2018)
- Form of Stock Option Grant Notice and Option Agreement (Performance-Based Vesting) for the 2018 Inducement Award Plan (Filed With SEC on August 7, 2018)
- Form of Restricted Stock Unit Award Grant Notice and Option Agreement (Performance-Based Vesting) for the 2014 Equity Incentive Plan (Filed With SEC on August 7, 2018)
- Form of Restricted Stock Unit Award Grant Notice and Option Agreement (Time-Based Vesting) for the 2014 Equity Incentive Plan (Filed With SEC on August 7, 2018)
- Form of Stock Option Grant Notice and Option Agreement for the 2014 Equity Incentive Plan (For awards after June 14, 2018) (Filed With SEC on August 7, 2018)
- Form of Amendment to Stock Option Grant Notice and Option Agreement for the 2014 Equity Incentive Plan (Filed With SEC on August 7, 2018)
- Separation and Consulting Agreement between the Company and Randall C. Schatzman dated March 26, 2018 (Filed With SEC on May 8, 2018)
- Separation and Consulting Agreement between Alder BioPharmaceuticals, Inc. and Timothy M. Whitaker, M.D., dated June 3, 2016 (Filed With SEC on February 26, 2018)
- Alder BioPharmaceuticals, Inc. Executive Severance Benefit Plan (Filed With SEC on February 23, 2017)
- ALDER BIOPHARMACEUTICALS, INC. EXECUTIVE SEVERANCE BENEFIT PLAN (Filed With SEC on April 25, 2014)
- ALDER BIOPHARMACEUTICALS, INC. STOCK OPTION GRANT NOTICE (2014 EQUITY INCENTIVE PLAN) (Filed With SEC on April 25, 2014)
- ALDER BIOPHARMACEUTICALS, INC. EXECUTIVE CHANGE IN CONTROL SEVERANCE BENEFITPLAN (Filed With SEC on March 19, 2014)
- ALDER BIOPHARMACEUTICALS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 31, 2014 APPROVED BY THE STOCKHOLDERS:APRIL 7, 2014 IPO DATE/EFFECTIVE DATE: ,... (Filed With SEC on April 25, 2014)
